Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Circulating tumor cells in lung cancer.
Young R, Pailler E, Billiot F, Drusch F, Barthelemy A, Oulhen M, Besse B, Soria JC, Farace F, Vielh P. Young R, et al. Among authors: billiot f. Acta Cytol. 2012;56(6):655-60. doi: 10.1159/000345182. Epub 2012 Nov 24. Acta Cytol. 2012. PMID: 23207444 Review.
Method for semi-automated microscopy of filtration-enriched circulating tumor cells.
Pailler E, Oulhen M, Billiot F, Galland A, Auger N, Faugeroux V, Laplace-Builhé C, Besse B, Loriot Y, Ngo-Camus M, Hemanda M, Lindsay CR, Soria JC, Vielh P, Farace F. Pailler E, et al. Among authors: billiot f. BMC Cancer. 2016 Jul 14;16:477. doi: 10.1186/s12885-016-2461-4. BMC Cancer. 2016. PMID: 27417942 Free PMC article.
Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK-Rearranged Non-Small Cell Lung Cancer Patients.
Pailler E, Oulhen M, Borget I, Remon J, Ross K, Auger N, Billiot F, Ngo Camus M, Commo F, Lindsay CR, Planchard D, Soria JC, Besse B, Farace F. Pailler E, et al. Among authors: billiot f. Cancer Res. 2017 May 1;77(9):2222-2230. doi: 10.1158/0008-5472.CAN-16-3072. Cancer Res. 2017. PMID: 28461563
Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors.
Farace F, Gross-Goupil M, Tournay E, Taylor M, Vimond N, Jacques N, Billiot F, Mauguen A, Hill C, Escudier B. Farace F, et al. Among authors: billiot f. Br J Cancer. 2011 Mar 29;104(7):1144-50. doi: 10.1038/bjc.2011.72. Epub 2011 Mar 8. Br J Cancer. 2011. PMID: 21386843 Free PMC article.
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas.
Farace F, Massard C, Vimond N, Drusch F, Jacques N, Billiot F, Laplanche A, Chauchereau A, Lacroix L, Planchard D, Le Moulec S, André F, Fizazi K, Soria JC, Vielh P. Farace F, et al. Among authors: billiot f. Br J Cancer. 2011 Sep 6;105(6):847-53. doi: 10.1038/bjc.2011.294. Epub 2011 Aug 9. Br J Cancer. 2011. PMID: 21829190 Free PMC article.
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study.
Massard C, Oulhen M, Le Moulec S, Auger N, Foulon S, Abou-Lovergne A, Billiot F, Valent A, Marty V, Loriot Y, Fizazi K, Vielh P, Farace F. Massard C, et al. Among authors: billiot f. Oncotarget. 2016 Aug 23;7(34):55069-55082. doi: 10.18632/oncotarget.10396. Oncotarget. 2016. PMID: 27391263 Free PMC article.
An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer.
Faugeroux V, Lefebvre C, Pailler E, Pierron V, Marcaillou C, Tourlet S, Billiot F, Dogan S, Oulhen M, Vielh P, Rameau P, NgoCamus M, Massard C, Laplace-Builhé C, Tibbe A, Taylor M, Soria JC, Fizazi K, Loriot Y, Julien S, Farace F. Faugeroux V, et al. Among authors: billiot f. Eur Urol Oncol. 2020 Aug;3(4):498-508. doi: 10.1016/j.euo.2018.12.005. Epub 2019 Jan 4. Eur Urol Oncol. 2020. PMID: 31412010 Free article.
29 results